Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 132127-34-5 | MDL No. : | MFCD07368374 |
Formula : | C9H9NO2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | FBZSDKXFQUKDLD-JGVFFNPUSA-N |
M.W : | 163.17 | Pubchem ID : | 10219589 |
Synonyms : |
|
Num. heavy atoms : | 12 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.22 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 2.0 |
Molar Refractivity : | 46.99 |
TPSA : | 49.33 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -7.14 cm/s |
Log Po/w (iLOGP) : | 1.21 |
Log Po/w (XLOGP3) : | 0.22 |
Log Po/w (WLOGP) : | -0.49 |
Log Po/w (MLOGP) : | 1.08 |
Log Po/w (SILICOS-IT) : | 1.02 |
Consensus Log Po/w : | 0.61 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.29 |
Solubility : | 8.29 mg/ml ; 0.0508 mol/l |
Class : | Very soluble |
Log S (Ali) : | -0.82 |
Solubility : | 25.0 mg/ml ; 0.153 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -2.12 |
Solubility : | 1.23 mg/ml ; 0.00755 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.85 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 52485-51-5 ]
(S)-N-(1-Hydroxy-3-phenylpropan-2-yl)acetamide
Similarity: 0.73
[ 17507-05-0 ]
1-Phenyl-1,2-dihydroisoquinolin-3(4H)-one
Similarity: 0.71
[ 1081548-91-5 ]
(1R,2R)-2-(Methylamino)-1,2-diphenylethanol
Similarity: 0.70
[ 2019-71-8 ]
2-Hydroxy-N,N-dimethyl-2-phenylacetamide
Similarity: 0.69
[ 52485-51-5 ]
(S)-N-(1-Hydroxy-3-phenylpropan-2-yl)acetamide
Similarity: 0.73
[ 1081548-91-5 ]
(1R,2R)-2-(Methylamino)-1,2-diphenylethanol
Similarity: 0.70
[ 322407-34-1 ]
(1S,2S)-2-(Benzylamino)cyclohexanol
Similarity: 0.68
[ 141553-09-5 ]
(1R,2R)-2-(Benzylamino)cyclohexanol
Similarity: 0.68
[ 1033605-25-2 ]
(1R,2R)-2-(Benzylamino)cyclopentanol
Similarity: 0.68
[ 52485-51-5 ]
(S)-N-(1-Hydroxy-3-phenylpropan-2-yl)acetamide
Similarity: 0.73
[ 17507-05-0 ]
1-Phenyl-1,2-dihydroisoquinolin-3(4H)-one
Similarity: 0.71
[ 207989-87-5 ]
5-(4-Hydroxyphenyl)pyrrolidin-2-one
Similarity: 0.69
[ 1347675-92-6 ]
(R)-N-(Tetrahydro-2H-pyran-3-yl)benzamide
Similarity: 0.67
[ 207989-87-5 ]
5-(4-Hydroxyphenyl)pyrrolidin-2-one
Similarity: 0.69
[ 1347675-92-6 ]
(R)-N-(Tetrahydro-2H-pyran-3-yl)benzamide
Similarity: 0.67
[ 90604-02-7 ]
1-Benzhydrylazetidin-3-ol hydrochloride
Similarity: 0.65
[ 90604-02-7 ]
1-Benzhydrylazetidin-3-ol hydrochloride
Similarity: 0.65
[ 1334536-88-7 ]
7-Benzyl-1-oxo-2,7-diazaspiro[3.5]nonane
Similarity: 0.65
[ 1375303-15-3 ]
2-(1-Benzhydrylazetidin-3-yl)propane-1,3-diol
Similarity: 0.61
[ 18085-37-5 ]
Methyl 1-benzylazetidine-2-carboxylate
Similarity: 0.60